Blueprint Medicines Corpo...

NASDAQ: BPMC · Real-Time Price · USD
129.46
0.18 (0.14%)
At close: Jul 17, 2025, 3:59 PM

Blueprint Medicines Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
102.01M 71.29M 119.71M 209.95M
Short-Term Investments
513.47M 639.36M 825.28M 267.17M
Long-Term Investments
277.15M 84.32M 161.27M 557.53M
Other Long-Term Assets
59.21M 40.89M 26.78M 19.81M
Receivables
77.61M 43.18M 36.94M 37.03M
Inventory
13.61M 21.22M 29.7M 21.82M
Other Current Assets
35.97M 33.35M 35.02M n/a
Total Current Assets
742.68M 808.39M 1.05B 554.02M
Property-Plant & Equipment
100.77M 115.65M 115.2M 120.86M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
437.13M 240.86M 303.25M 698.2M
Total Assets
1.18B 1.05B 1.35B 1.25B
Account Payables
6.79M 4.71M 2.73M 8.33M
Deferred Revenue
2M 812K 448.62M 36.58M
Short-Term Debt
43.92M 69.48M 16.85M 8.09M
Other Current Liabilities
208.08M 60.9M 31M 84.57M
Total Current Liabilities
260.8M 214.92M 183.23M 149.76M
Long-Term Debt
343.05M 610.96M 122.23M n/a
Other Long-Term Liabilities
277.3M 6.21M 436.97M 3.34M
Total Long-Term Liabilities
620.35M 703.72M 651.99M 131.72M
Total Liabilities
881.15M 918.64M 835.23M 281.49M
Total Debt
469.11M 774.12M 242.45M 111.41M
Common Stock
64K 61K 60K 59K
Retained Earnings
-2.41B -2.34B -1.83B -1.28B
Comprehensive Income
-3.55M -3.5M -10.44M -4.13M
Shareholders Equity
298.67M 130.61M 514.68M 970.74M
Total Investments
790.62M 723.67M 958.76M 824.7M